Texas Yale Capital Corp’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$208K Hold
16,000
0.01% 449
2025
Q1
$169K Hold
16,000
0.01% 438
2024
Q4
$272K Hold
16,000
0.01% 405
2024
Q3
$371K Hold
16,000
0.02% 363
2024
Q2
$390K Buy
+16,000
New +$390K 0.02% 343